enprofylline has been researched along with Sleep Wake Disorders in 1 studies
enprofylline : Xanthine bearing a propyl substituent at position 3. A bronchodilator, it is used for the symptomatic treatment of asthma and chronic obstructive pulmonary disease, and in the management of cerebrovascular insufficiency, sickle cell disease, and diabetic neuropathy.
Sleep Wake Disorders: Abnormal sleep-wake schedule or pattern associated with the CIRCADIAN RHYTHM which affect the length, timing, and/or rigidity of the sleep-wake cycle relative to the day-night cycle.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janson, C | 1 |
| Gislason, T | 1 |
| Laxmyr, L | 1 |
| Boman, G | 1 |
| Persson, C | 1 |
1 trial available for enprofylline and Sleep Wake Disorders
| Article | Year |
|---|---|
Sleep disturbances in asthma: theophylline versus enprofylline.
Topics: Adult; Aged; Aminophylline; Asthma; Bronchodilator Agents; Female; Humans; Male; Middle Aged; Sleep | 1991 |